Xencor Inc
F:XE9
Xencor Inc
F:XE9
Price:
10.1
EUR
5.76%
Market Closed
Market Cap:
€622.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xencor Inc
F:XE9
|
US |
|
A
|
Ascopiave SpA
DUS:AVA
|
IT |
|
I
|
Intel Corp
SGO:INTC
|
US |
|
S
|
Seoam Machinery Industry Co Ltd
KOSDAQ:100660
|
KR |
|
R
|
Rock Ridge Resources Inc
OTC:RRRI
|
US |
|
S
|
SAB Finance as
PSE:SABFG
|
CZ |
|
VP Bank AG
F:3VFN
|
LI |
|
ContextVision AB
OSE:CONTX
|
SE |
|
Z
|
Zaigle Co Ltd
KOSDAQ:234920
|
KR |
|
Amazia Inc
TSE:4424
|
JP |
|
Australian Dairy Nutritionals Group
ASX:AHF
|
AU |
|
R
|
Revolution Beauty Group PLC
LSE:REVB
|
UK |
|
Hempacco Co Inc
OTC:HPCO
|
US |
|
R
|
River Hawk Aviation Inc
OTC:RHWI
|
US |
|
E
|
Exxon Mobil Corp
BMV:XOM
|
US |
|
MJ Gleeson PLC
LSE:GLE
|
UK |
|
I
|
INC SA
WSE:INC
|
PL |
|
Upbound Group Inc
NASDAQ:UPBD
|
US |
|
H
|
Helio SA
WSE:HEL
|
PL |
|
I
|
Israel Shipyards Ltd
TASE:ISHI
|
IL |
|
BHCC Holding Ltd
HKEX:1552
|
SG |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
Multiples-Based Value
The Multiples-Based Value of one
XE9
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 10.1 EUR,
Xencor Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XE9 Multiples-Based Value
LOCKED
Multiples Across Competitors
XE9 Competitors Multiples
Xencor Inc Competitors
Xencor Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Xencor Inc
F:XE9
|
920.7m EUR | 7.3 | -10 | -2.7 | -2.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
